The Prostate Cancer Foundation (PCF) will convene leading researchers, clinicians and industry experts at its 33rd Annual Scientific Retreat, October 2–4, 2026, in Carlsbad, California. The Retreat is ...
The Georgetown University Lombardi Comprehensive Cancer Center held a lecture on how certain white blood cells in the immune system can contribute to bone metastatic prostate cancer as part of their ...
For more than a decade, patients facing certain types of prostate cancer have been able to turn to Xtandi, the now-brand name of enzalutamide, a compound breakthrough developed in the lab of Michael ...